• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

次要组织相容性抗原HA-1、-2和-4以及HY特异性细胞毒性T细胞克隆通过一种依赖直接细胞间接触的机制抑制人类造血祖细胞的生长。

Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.

作者信息

Marijt W A, Veenhof W F, Goulmy E, Willemze R, van Rood J J, Falkenburg J H

机构信息

Department of Hematology, University Medical Center, Leiden, The Netherlands.

出版信息

Blood. 1993 Dec 15;82(12):3778-85.

PMID:8260714
Abstract

HLA-identical bone marrow transplantation (BMT) may be complicated by graft-versus-host disease or graft rejection. Both complications are thought to be initiated by recognition of minor histocompatibility (mH) antigens by HLA-restricted mH-antigen-specific T lymphocytes. Using HLA-A2-restricted mH antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T lymphocyte (CTL) clones, we studied the recognition by these CTL clones of interleukin-2 (IL-2)-stimulated T cells (IL-2 blasts), BM mononuclear cells (BMMNCs), and hematopoietic progenitor cells (HPCs). We showed that, when IL-2 blasts from the BM donors who were investigated were recognized by the HA-1-, -2-, and -4-, and HY-specific CTL clones, their BMMNCs and HPCs were recognized as well by these CTL clones, resulting in antigen-specific growth inhibition of erythrocyte burst-forming units (BFU-E), colony-forming units-granulocyte (CFU-G), and CFU-macrophage (CFU-M). the HA-2-specific CTL clone, however, inhibited BFU-E and CFU-G growth from four donors to a lesser extent than from two other donors. We further investigated whether inhibitory cytokines released into the culture medium by the antigen-specific stimulated CTLs or by stimulated BMMNCs were responsible for suppression of HPC growth or whether this effect was caused by direct cell-cell contact between CTLs and HPCs. HPC growth inhibition was only observed after preincubation of BMMNCs and CTLs together for 4 hours before plating the cells in semisolid HPC culture medium. When no cell-cell contact was permitted before plating, neither antigen-stimulated CTL nor antigen-nonstimulated CTLs provoked HPC growth inhibition. Culturing BMMNCs in the presence of supernatants harvested after incubation of BMMNCs and CTL clones together for 4 or 72 hours did also not result in HPC growth inhibition. Both suppression of HPC growth and lysis of IL-2 blasts and BMMNCs in the 51Cr-release assay appeared to be dependent on direct cell-cell contact between target cells and CTLs and were not caused by the release of inhibitory cytokines into the culture medium by antigen-specific stimulated CTLs or by stimulated BMMNCs. Our results show that mH-antigen-specific CTLs can inhibit HPC growth by a direct cytolytic effect and may therefore be responsible for BM graft rejection after HLA-identical BMT.

摘要

人类白细胞抗原(HLA)相合的骨髓移植(BMT)可能会并发移植物抗宿主病或移植物排斥反应。这两种并发症被认为是由HLA限制性微小组织相容性(mH)抗原特异性T淋巴细胞识别mH抗原引发的。利用HLA - A2限制性mH抗原HA - 1、- 2和- 4以及HY特异性细胞毒性T淋巴细胞(CTL)克隆,我们研究了这些CTL克隆对白细胞介素-2(IL - 2)刺激的T细胞(IL - 2母细胞)、骨髓单个核细胞(BMMNCs)和造血祖细胞(HPCs)的识别情况。我们发现,当来自被研究的骨髓供体的IL - 2母细胞被HA - 1、- 2、- 4和HY特异性CTL克隆识别时,它们的BMMNCs和HPCs也会被这些CTL克隆识别,从而导致红细胞爆式集落形成单位(BFU - E)、粒细胞集落形成单位(CFU - G)和巨噬细胞集落形成单位(CFU - M)的抗原特异性生长抑制。然而,HA - 2特异性CTL克隆对来自四个供体的BFU - E和CFU - G生长的抑制程度低于对另外两个供体的抑制程度。我们进一步研究了抗原特异性刺激的CTL或刺激的BMMNCs释放到培养基中的抑制性细胞因子是否是HPC生长受抑制的原因,或者这种效应是否是由CTL与HPC之间的直接细胞间接触引起的。只有在将BMMNCs和CTL一起预孵育4小时后再接种到半固体HPC培养基中,才观察到HPC生长受到抑制。如果在接种前不允许细胞间接触,那么无论是抗原刺激的CTL还是未受抗原刺激的CTL都不会引发HPC生长抑制。在BMMNCs与CTL克隆一起孵育4或72小时后收集的上清液存在的情况下培养BMMNCs,也不会导致HPC生长抑制。在51Cr释放试验中,HPC生长抑制以及IL - 2母细胞和BMMNCs的裂解似乎都依赖于靶细胞与CTL之间的直接细胞间接触,而不是由抗原特异性刺激的CTL或刺激的BMMNCs释放抑制性细胞因子到培养基中所导致的。我们的结果表明,mH抗原特异性CTL可通过直接细胞溶解作用抑制HPC生长,因此可能是HLA相合BMT后骨髓移植物排斥反应的原因。

相似文献

1
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.次要组织相容性抗原HA-1、-2和-4以及HY特异性细胞毒性T细胞克隆通过一种依赖直接细胞间接触的机制抑制人类造血祖细胞的生长。
Blood. 1993 Dec 15;82(12):3778-85.
2
Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.通过与 HLA 相同的骨髓细胞刺激,能够在体外产生可裂解人类造血祖细胞的次要组织相容性抗原特异性细胞毒性 T 细胞系。
J Exp Med. 1991 Jan 1;173(1):101-9. doi: 10.1084/jem.173.1.101.
3
Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.通过CD8 +或CD4 +次要组织相容性抗原特异性细胞毒性T淋巴细胞识别克隆性白血病细胞、缓解期骨髓和HLA匹配供体骨髓。
J Clin Invest. 1995 Aug;96(2):877-83. doi: 10.1172/JCI118134.
4
Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.在 HLA 配型相同的骨髓移植后的移植物排斥反应过程中,可产生多种次要组织相容性抗原特异性细胞毒性 T 淋巴细胞克隆。
Bone Marrow Transplant. 1995 Jul;16(1):125-32.
5
Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.次要组织相容性抗原特异性细胞毒性T淋巴细胞对克隆性白血病前体细胞的生长抑制作用。
J Exp Med. 1991 Jul 1;174(1):27-33. doi: 10.1084/jem.174.1.27.
6
Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.从一位异基因骨髓移植后发生严重移植物抗宿主病的患者中产生CD4+细胞毒性T淋巴细胞克隆:对移植物抗白血病反应的影响。
Blood. 1995 Oct 1;86(7):2821-8.
7
Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.利用慢性粒细胞白血病细胞作为刺激物,在α干扰素存在的情况下,无需体内预刺激即可在体外产生次要组织相容性抗原特异性、白血病反应性细胞毒性T细胞克隆。
Biol Blood Marrow Transplant. 1996 Feb;2(1):31-6.
8
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.骨髓移植受者与四位 HLA 匹配的潜在同胞供者之间存在多种次要组织相容性抗原差异。
Hum Immunol. 1993 Aug;37(4):221-8. doi: 10.1016/0198-8859(93)90505-u.
9
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.UTY基因编码一种与干细胞移植排斥相关的、受HLA - B60限制的人类男性特异性次要组织相容性抗原:T细胞识别关键多态性氨基酸残基的特征分析。
Blood. 2000 Nov 1;96(9):3126-32.
10
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.四聚体 HLA I 类-次要组织相容性抗原肽复合物可在移植物抗宿主病患者中证实次要组织相容性抗原特异性细胞毒性 T 淋巴细胞。
Nat Med. 1999 Jul;5(7):839-42. doi: 10.1038/10563.

引用本文的文献

1
Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.次要组织相容性抗原在干细胞移植后供体嵌合体持续存在中的可能作用;与白血病持续缓解的相关性。
PLoS One. 2015 Mar 16;10(3):e0119595. doi: 10.1371/journal.pone.0119595. eCollection 2015.
2
Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.次要组织相容性抗原错配在人类白细胞抗原匹配的非亲缘造血干细胞移植中对临床结局的影响。
Biol Blood Marrow Transplant. 2009 Jul;15(7):856-63. doi: 10.1016/j.bbmt.2009.03.018.
3
Evidence for ineffective erythropoiesis in severe sickle cell disease.
重度镰状细胞病中红细胞生成无效的证据。
Blood. 2005 Nov 15;106(10):3639-45. doi: 10.1182/blood-2005-04-1376. Epub 2005 Aug 9.
4
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.一种新型人类次要组织相容性抗原的免疫原性源于不同的抗原加工过程。
J Exp Med. 2001 Jan 15;193(2):195-206. doi: 10.1084/jem.193.2.195.
5
Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.通过CD8 +或CD4 +次要组织相容性抗原特异性细胞毒性T淋巴细胞识别克隆性白血病细胞、缓解期骨髓和HLA匹配供体骨髓。
J Clin Invest. 1995 Aug;96(2):877-83. doi: 10.1172/JCI118134.
6
Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).系统性红斑狼疮(SLE)患者的IgG自身抗体对造血的抑制作用。
Clin Exp Immunol. 1995 Jun;100(3):480-5. doi: 10.1111/j.1365-2249.1995.tb03726.x.